Theialife is open to collaborations with biotechnology, pharmaceutical, and other strategic partners to discover, develop and commercialize innovative treatments in the fields of ophthalmology & ocular diseases. We welcome opportunities to partner through in- and out-licensure, co-development, region-specific agreements, joint ventures, and other collaborations.

Theialife is committed to developing first- and/or best-in-class therapeutics for vision-threatening diseases – to help patients see better & have a better quality of life.

Sight-threatening diseases constitute a large and growing market opportunity. With changing population demographics, the incidence of many ocular diseases, especially Myopia is increasing. New, innovative & novel therapies are required to treat this silent epidemic. If you are interested in joining in this journey to protect the vision of children all over the world, please feel free to get in touch.